Apogee begins patient dosing in Part B of phase 2 APEX trial of APG777 to treat moderate-to-severe atopic dermatitis: San Francisco Tuesday, February 4, 2025, 18:00 Hrs [IST] Apog ...
Arbutus Biopharma (NASDAQ:ABUS) was able to report positive data from its phase 2a IM-PROVE I trial, which used its drug Imdusiran [AB-729] together with short courses of pegylated interferon alfa ...
Followed categories will be added to My News. All subjects enrolled in Island Pharmaceutical’s phase 2b arm of phase 2a/b PROTECT trial of ISLA-101 in dengue fever Phase 2b study will explore ability ...
All subjects enrolled in Island Pharmaceutical’s phase 2b arm of phase 2a/b PROTECT trial of ISLA-101 in dengue fever Phase 2b study will explore ability of ISLA-101 to reduce symptoms of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback